University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Inhaled Corticosteroid Adherence Patterns in a Longitudinal Asthma Cohort

Simple item page
dc.contributor.authorSouverein, Patrick C
dc.contributor.authorKoster, Ellen S
dc.contributor.authorColice, Gene
dc.contributor.authorvan Ganse, Eric
dc.contributor.authorChisholm, Alison
dc.contributor.authorPrice, David
dc.contributor.authorDima, Alexandra L
dc.contributor.authorRespiratory Effectiveness Group's Adherence Working Group
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2017-11-02T00:02:06Z
dc.date.available2017-11-02T00:02:06Z
dc.date.embargoedUntil2017-11-01
dc.date.issued2017-03-01
dc.descriptionAcknowledgments The authors would like to thank Hilary Pinnock, Nemr Eid, Randal Brown, Miguel Román Rodriguez, Janet Holbrook, Michelle Eakin, Cynthia Rand, and Iain Small for reviewing the study protocol. This study was funded by the Respiratory Effectiveness Group, an international, investigator-led, not-for-profit, real-life respiratory research and advocacy initiative (www.effectivenessevaluation.org). Conflicts of interest: P. C. Souverein, E. S. Koster, and A. L. Dima have received research support from the Respiratory Effectiveness Group. G. Colice is employed by and has stock/stock options in AstraZeneca. E. van Ganse has received research support from personal fees from ALK Abello, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Merck Sharp, and Dohme and has received personal fees from AstraZeneca, Boehringer Ingelheim, Intercontinental Marketing Services (IMS), and LASER. A. Chisholm declares no relevant conflicts of interest. D. Price is on the boards for Aerocrine, Almirall, Amgen Inc, AstraZeneca plc, Boehringer Ingelheim, Chiesi, Meda, Mundipharma, Napp, Novartis International AG, and Teva (fees paid to Research in Real Life Ltd); has received consultancy fees from Almirall, Amgen Inc, AstraZeneca plc, Boehringer Ingelheim, Chiesi, GlaxoSmithKline plc, Meda, Mundipharma, Napp, Novartis International AG, Pfizer, Inc, and Teva (fees paid to Research in Real Life Ltd); has received research support from UK National Health Service, British Lung Foundation, Aerocrine, AKL Ltd, Almirall, AstraZeneca plc, Boehringer Ingelheim, Chiesi, Eli Lilly, GlaxoSmithKline plc, Meda, Merck & Co., Inc, Mundipharma, Napp, Novartis International AG, Orion, Pfizer, Inc, Respiratory Effectiveness Group, Takeda, Teva, and Zentiva; has received lecture fees from Almirall, AstraZeneca plc, Boehringer Ingelheim, Chiesi, Cipla, GlaxoSmithKline plc, Kyorin, Meda, Merck & Co., Inc, Mundipharma, Novartis International AG, Pfizer, Inc, Skyepharma, Takeda, and Teva (fees paid to Research in Real Life Ltd); has received payment for manuscript preparation from Mundipharma and Teva (fees paid to Research in Real Life Ltd); has a patent with AKL Ltd for Phytopharmaceuticals; has received payment for development from GlaxoSmithKline and Novartis International AG (fees paid to Research in Real Life Ltd); has stock in AKL Ltd; has received travel support from Aerocrine, Boehringer Ingelheim, Mundipharma, Napp, Novartis International AG, and Teva (fees paid to Research in Real Life Ltd); has received funding for patient enrollment or completion of research from Almirall, Chiesi, Teva, and Zentiva (fees paid to Research in Real Life Ltd); is a peer reviewer for the grant committees of the Medical Research Council, Efficacy and Mechanism Evaluation programme; and owns 80% of Research in Real Life Ltd (which is subcontracted by Observational and Pragmatic Research Institute Pte Ltd), 75% of the social enterprise Optimum Patient Care Ltd, and 75% of Observational and Pragmatic Research Institute Pte Ltd.en
dc.description.statusPeer revieweden
dc.format.extent9
dc.format.extent173687
dc.format.extent555000
dc.identifier74188366
dc.identifier9351db2d-a72b-4381-9178-ef44e2895fc2
dc.identifier27815064
dc.identifier85003815262
dc.identifier.citationSouverein, P C, Koster, E S, Colice, G, van Ganse, E, Chisholm, A, Price, D, Dima, A L & Respiratory Effectiveness Group's Adherence Working Group 2017, 'Inhaled Corticosteroid Adherence Patterns in a Longitudinal Asthma Cohort', The journal of allergy and clinical immunology. In practice, vol. 5, no. 2, pp. 448–456. https://doi.org/10.1016/j.jaip.2016.09.022en
dc.identifier.doi10.1016/j.jaip.2016.09.022
dc.identifier.iss2en
dc.identifier.issn2213-2201
dc.identifier.urihttp://hdl.handle.net/2164/9556
dc.identifier.vol5en
dc.language.isoeng
dc.relation.ispartofThe journal of allergy and clinical immunology. In practiceen
dc.subjectadherenceen
dc.subjectasthmaen
dc.subjectCMAen
dc.subjectinhaled corticosteroidsen
dc.subjectOPCRDen
dc.subjectpharmacoepidemiologyen
dc.subjectcohort studyen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleInhaled Corticosteroid Adherence Patterns in a Longitudinal Asthma Cohorten
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 2 of 2
No Thumbnail Available
Name:
Supplementary_Tables_nomarkup.docx
Size:
169.62 KB
Format:
Unknown data format
Download
No Thumbnail Available
Name:
Paper_REG_phase_1_revision_30june2016_endnoteremoved_nomarkkup.docx
Size:
541.99 KB
Format:
Unknown data format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description:
Download

Collections

All research
Applied Health Sciences research
University Office research